​

Sagittarius Life Science Corp

TPEX:3205 Stock Report

Market Cap: NT$1.6b

Sagittarius Life Science (3205) Stock Overview

Engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. More details

3205 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the TW market

Does not have a meaningful market cap (NT$2B)


3205 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Sagittarius Life Science Corp Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sagittarius Life Science
Historical stock prices
Current Share PriceNT$50.20
52 Week HighNT$57.90
52 Week LowNT$21.30
Beta0.69
1 Month Change18.82%
3 Month Change124.61%
1 Year Change10.69%
3 Year Change17.84%
5 Year Change16.47%
Change since IPO-58.11%

Recent News & Updates

Recent updates

We Think Sagittarius Life Science (GTSM:3205) Can Afford To Drive Business Growth

Apr 11
We Think Sagittarius Life Science (GTSM:3205) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Sagittarius Life Science's (GTSM:3205) Cash Burn Situation

Dec 27
Here's Why We're Not Too Worried About Sagittarius Life Science's (GTSM:3205) Cash Burn Situation

Shareholder Returns

3205TW Personal ProductsTW Market
7D-4.9%2.1%0.6%
1Y10.7%-29.1%-7.1%

Return vs Industry: 3205 exceeded the TW Personal Products industry which returned -29.1% over the past year.

Return vs Market: 3205 exceeded the TW Market which returned -7.1% over the past year.

Price Volatility

Is 3205's price volatile compared to industry and market?
3205 volatility
3205 Average Weekly Movement11.6%
Personal Products Industry Average Movement5.3%
Market Average Movement6.6%
10% most volatile stocks in TW Market9.4%
10% least volatile stocks in TW Market4.1%

Stable Share Price: 3205's share price has been volatile over the past 3 months compared to the TW market.

Volatility Over Time: 3205's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
1998n/aJunheng Chenwww.naturalbiokey.com

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.

Sagittarius Life Science Corp Fundamentals Summary

How do Sagittarius Life Science's earnings and revenue compare to its market cap?
3205 fundamental statistics
Market capNT$1.63b
Earnings (TTM)-NT$54.87m
Revenue (TTM)NT$451.65m
3.6x
P/S Ratio
-29.8x
P/E Ratio

Is 3205 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
3205 income statement (TTM)
RevenueNT$451.65m
Cost of RevenueNT$370.47m
Gross ProfitNT$81.18m
Other ExpensesNT$136.06m
Earnings-NT$54.87m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-1.69
Gross Margin17.97%
Net Profit Margin-12.15%
Debt/Equity Ratio0%

How did 3205 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/08 00:21
End of Day Share Price 2025/07/08 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sagittarius Life Science Corp is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.